Matches in Nanopublications for { ?s ?p "[NAT1 fast acetylators had a significantly higher risk of CRC than NAT1 slow acetylators, whereas NAT2 acetylator status did not affect the CRC risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 3 of
3
with 100 items per page.
- NP536430.RAWGefeOLiCEk_0LfObuERKi_vdF_hGB6b3COpj3MVyAw130_assertion description "[NAT1 fast acetylators had a significantly higher risk of CRC than NAT1 slow acetylators, whereas NAT2 acetylator status did not affect the CRC risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP536430.RAWGefeOLiCEk_0LfObuERKi_vdF_hGB6b3COpj3MVyAw130_provenance.
- NP595806.RAeYnrHwtzz1C8vEcBbskhQQvQLacoODAA7vr3JXtFWpM130_assertion description "[NAT1 fast acetylators had a significantly higher risk of CRC than NAT1 slow acetylators, whereas NAT2 acetylator status did not affect the CRC risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP595806.RAeYnrHwtzz1C8vEcBbskhQQvQLacoODAA7vr3JXtFWpM130_provenance.
- NP619469.RAMnq743dz-Z05mAJL-q7azgwkvPMC5BONOZ_25EgZ5hE130_assertion description "[NAT1 fast acetylators had a significantly higher risk of CRC than NAT1 slow acetylators, whereas NAT2 acetylator status did not affect the CRC risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619469.RAMnq743dz-Z05mAJL-q7azgwkvPMC5BONOZ_25EgZ5hE130_provenance.